Source: Gold Mountain
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Gold Mountain (GMN) raises $2.25 million through a placement to sophisticated and professional investors
  • The funds will go toward lithium exploration activities in Brazil
  • The company will issue 300 million new shares at an issue price of 0.75 cents each
  • The funds will also further exploration at the company’s Wabag project in Papua New Guinea
  • Shares are up 11 per cent, trading at 1 cent at 12:26 pm AEST

Gold Mountain (GMN) has raised $2.25 million through a placement to sophisticated and professional investors to further lithium exploration activities in Brazil.

The funds were raised through the issuance of around 300 million new shares at 0.75 cents each.

“We are very pleased with the strong support for the placement from new and existing investors,” GMN Executive Director David Evans said.

“We believe the strong demand for this capital raising is a testament to the quality of the company’s projects”.

Additional to lithium exploration in Brazil, the company will also use the funds to further exploration at the company’s Wabag project in Papua New Guinea.

The company increased its stake in its Brazilian acreage in January of this year.

Gold Mountain shares were up 11 per cent, trading at 1 cent at 12:26 pm AEST.

GMN by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.